Mexico Immunotherapy Drugs Market Size & Outlook, 2026-2033

The immunotherapy drugs market in Mexico is expected to reach a projected revenue of US$ 8,530.5 million by 2033. A compound annual growth rate of 14% is expected of Mexico immunotherapy drugs market from 2026 to 2033.
Revenue, 2025 (US$M)
$2,985.9
Forecast, 2033 (US$M)
$8,530.5
CAGR, 2026 - 2033
14%
Report Coverage
Mexico

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Mexico immunotherapy drugs market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Mexico immunotherapy drugs market highlights

  • The Mexico immunotherapy drugs market generated a revenue of USD 2,985.9 million in 2025 and is expected to reach USD 8,530.5 million by 2033.
  • The Mexico market is expected to grow at a CAGR of 14% from 2026 to 2033.
  • In terms of segment, monoclonal antibodies was the largest revenue generating drug type in 2025.
  • Vaccine is the most lucrative drug type segment registering the fastest growth during the forecast period.


Immunotherapy drugs market data book summary

Market revenue in 2025USD 2,985.9 million
Market revenue in 2033USD 8,530.5 million
Growth rate14% (CAGR from 2026 to 2033)
Largest segmentMonoclonal antibodies
Fastest growing segmentVaccine
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationMonoclonal Antibodies, Immunomodulator, Vaccine
Key market players worldwideAmgen Inc, Novartis AG ADR, AbbVie Inc., Pfizer Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., AstraZeneca PLC, GSK PLC ADR, Sanofi SA, Bayer AG


Other key industry trends

  • In terms of revenue, Mexico accounted for 1.0% of the global immunotherapy drugs market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In North America, U.S. immunotherapy drugs market is projected to lead the regional market in terms of revenue in 2033.
  • Mexico is the fastest growing regional market in North America and is projected to reach USD 8,530.5 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Immunotherapy Drugs Market Scope

Immunotherapy drugs market segmentation & scope
Monoclonal Antibodies
Immunomodulator
Vaccine
Others
Cancer
Autoimmune Diseases
Infectious Diseases
Others

Immunotherapy Drugs Market Companies

Name Profile # Employees HQ Website
Johnson & Johnson Services, Inc. View profile - - -
Pfizer Inc. View profile - - -
F. Hoffmann-La Roche Ltd. View profile - - -
AbbVie Inc. View profile - - -
AstraZeneca PLC View profile 89900 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA https://www.astrazeneca.com
Bayer AG View profile 99723 Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 https://www.bayer.com
GSK PLC ADR View profile 70200 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS https://www.gsk.com
Sanofi SA View profile 87994 46, avenue de la Grande Armée, Paris, France, 75017 https://www.sanofi.com
Amgen Inc View profile 26700 One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 https://www.amgen.com
Novartis AG ADR View profile 76057 Lichtstrasse 35, Basel, Switzerland, 4056 https://www.novartis.com

Mexico immunotherapy drugs market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immunotherapy drugs market will help companies and investors design strategic landscapes.


Monoclonal antibodies was the largest segment with a revenue share of 64.96% in 2025. Horizon Databook has segmented the Mexico immunotherapy drugs market based on monoclonal antibodies, immunomodulator, vaccine covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to Mexico immunotherapy drugs market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Mexico immunotherapy drugs market databook

  • Our clientele includes a mix of immunotherapy drugs market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Mexico immunotherapy drugs market , including forecasts for subscribers. This country databook contains high-level insights into Mexico immunotherapy drugs market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Mexico immunotherapy drugs market size, by drug type, 2021-2033 (US$M)

Mexico Immunotherapy Drugs Market Outlook Share, 2025 & 2033 (US$M)

Mexico immunotherapy drugs market size, by drug type, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online